Related Experiment Video
Updated: Jul 1, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
Rifampicin, ethambutol and pyrazinamide-induced thrombocytopenia
1Department of Pulmonary Medicine, Chhatrapati Shahuji Maharaj Medical University, Lucknow, Uttar Pradesh, India.
Abstract:
Drug-induced thrombocytopenia is an uncommon but serious side effect of many drugs including antituberculosis drugs. It is difficult to diagnose but easy to prevent just by stopping the exposure to the same drug again. In some cases, it can prove fatal if not taken care of urgently. Here, we report a case of thrombocytopenia due to rifampicin, ethambutol and pyrazinamide all in an adult male, which we believe is the first to be reported.
Related Concept Videos
Inhibitors of Bacterial Protein Synthesis
Pharmacokinetics: Drug–Drug Interactions
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Drugs that Destabilize Microtubules
Antiprotozoal Agents